ArticleJournal for immunotherapy of cancer2025

Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis.

Kim Nikola Oliva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.